The Valley Desk

NCT04903626 · Interventional trial

Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE)/Pibrentasvir (PIB)

Overall registry status Completed

Phase 3

Conditions Hepatitis C Virus (HCV)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov